0001628280-23-023651.txt : 20230627
0001628280-23-023651.hdr.sgml : 20230627
20230627184019
ACCESSION NUMBER: 0001628280-23-023651
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230623
FILED AS OF DATE: 20230627
DATE AS OF CHANGE: 20230627
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blanks Robert
CENTRAL INDEX KEY: 0001815433
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36485
FILM NUMBER: 231048800
MAIL ADDRESS:
STREET 1: C/O ARDELYX
STREET 2: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARDELYX, INC.
CENTRAL INDEX KEY: 0001437402
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
BUSINESS PHONE: 510-745-7047
MAIL ADDRESS:
STREET 1: 34175 ARDENWOOD BLVD.
CITY: FREMONT
STATE: CA
ZIP: 94555
FORMER COMPANY:
FORMER CONFORMED NAME: NTERYX INC
DATE OF NAME CHANGE: 20080611
4
1
wk-form4_1687905603.xml
FORM 4
X0407
4
2023-06-23
0
0001437402
ARDELYX, INC.
ARDX
0001815433
Blanks Robert
C/O ARDELYX, INC.
400 FIFTH AVENUE, SUITE 210
WALTHAM
MA
02451
0
1
0
0
See Remarks
1
Common Stock
2023-06-23
4
M
0
33333
3.42
A
299467
D
Common Stock
2023-06-23
4
S
0
33333
3.6313
D
266134
D
Stock Option (Right to Buy)
3.42
2023-06-23
4
M
0
33333
0
D
2014-07-18
2023-07-18
Common Stock
33333
0
D
This transaction relates an option that would have expired on July 18, 2023 and does not result in a reduction of shares held outright by the Reporting Person. The shares acquired upon the exercise of the option were sold pursuant to a Rule 10b5-1 stock trading plan adopted by the Reporting Person on March 24, 2023. accordingly, the Reporting Person had no discretion with regard to the timing of the transaction.
This transaction was executed in multiple trades in prices ranging from $3.62 to $3.70, inclusive. The price reported in Column 4 above reflects the weighted average sales price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The option, which was granted on July 18, 2013, and has an expiration date of July 18, 2023, is fully vested and exercisable.
Chief Regulatory and Quality Affairs Officer
/s/ Elizabeth Grammer, Attorney-in-Fact for Robert Blanks
2023-06-27